The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids

Puri, Puneet, Daita, Kalyani, Joyce, Andrew, Mirshahi, Faridoddin, Santhekadur, Prasanna K., Cazanave, Sophie, Luketic, Velimir A, Siddiqui, Mohammad S. +9 more·2018·Hepatology

DOI 10.1002/hep.29359

Cited by (426)

Items 101–200 of 426

Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases
Yanyan Wang, Huangru Xu, Xiqiao Zhou, Weidong Chen, Huiping Zhou · 2024 · Medical Review
Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges
Ming Li, Qian Wang, Yong Li, Shengtian Cao, Ying‐Jun Zhang, Zhongqing Wang, Guozhu Liu, Jing Li, Baohua Gu · 2020 · Pharmacology & Therapeutics
Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease
Chao Sang, Xiaoning Wang, Kejun Zhou, Tao Sun, Hua Bian, Xin Gao, Yixing Wang, Hua Zhang, Wei Ping Jia, Ping Liu et al. · 2021 · Journal of Proteome Research
Targeting the FGF19–FGFR4 pathway for cholestatic, metabolic, and cancerous diseases
Xiaokun Li, Weiqin Lu, Alexei Kharitonenkov, Yongde Luo · 2024 · Journal of Internal Medicine
A Low Glycemic Index Mediterranean Diet Combined with Aerobic Physical Activity Rearranges the Gut Microbiota Signature in NAFLD Patients
Francesco Maria Calabrese, Vittoria Disciglio, Isabella Franco, Paolo Sorino, Caterina Bonfiglio, Antonella Bianco, Angelo Campanella, Tamara Lippolis, Pasqua Letizia Pesole, Maurizio Gaetano Polignano et al. · 2022 · Nutrients
Inhibition of microbial deconjugation of micellar bile acids protects against intestinal permeability and liver injury
Darrick K. Li, Snehal N. Chaudhari, Mozhdeh Sojoodi, Yoojin Lee, Arijit A. Adhikari, Lawrence R. Zukerberg, Stuti G. Shroff, Stephen Cole Barrett, Kenneth K. Tanabe, Raymond T. Chung et al. · 2022 · Science Advances
Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis
Maria Cerreto, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani · 2021 · Nutrients
Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
Koning, Mijra, Herrema, Hilde, Nieuwdorp, Max, Meijnikman, Abraham S. · 2023 · Gut Microbes
Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat
Eric Lawitz, Bal Raj Bhandari, Peter Jerome Ruane, Anita Kohli, Eliza Harting, Dora Ding, Jen-Chieh Chuang, Ryan S. Huss, Chuhan Chung, Robert P. Myers et al. · 2022 · Clinical Gastroenterology and Hepatology
Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism in patients with nonalcoholic simple fatty liver disease: a randomized controlled trial
Youming He, Xiaobing Chen, Yongchun Li, Yunyi Liang, Ting Hong, Jie Yang, Zhuo Cao, Haiyan Mai, Jiale Yao, Tong Zhang et al. · 2024 · American Journal of Clinical Nutrition
Gut microbial metabolites in MASLD: Implications of mitochondrial dysfunction in the pathogenesis and treatment
Ruhan Zhang, Zhaobo Yan, Huan Zhong, Luo Rong, Weiai Liu, Shulin Xiong, Qianyan Liu, Mi Liu · 2024 · Hepatology Communications
Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice
Yufang Ding, Karin Yanagi, Fang Yang, Evelyn S. Callaway, Clint Cheng, Martha E. Hensel, Rani Menon, Robert Christopher Alaniz, Kyongbum Lee, Arul Jayaraman · 2023 · eLife
Bisphenol A induced hepatic steatosis by disturbing bile acid metabolism and FXR/TGR5 signaling pathways via remodeling the gut microbiota in CD-1 mice
Ting Hong, Jun Zou, Youming He, Hongmin Zhang, Hao Liu, Haiyan Mai, Jie Yang, Zhuo Cao, Xiaobing Chen, Jiale Yao et al. · 2023 · The Science of The Total Environment
The Crosstalk between Gut Microbiota and Bile Acids Promotes the Development of Non-Alcoholic Fatty Liver Disease
Zhonglin Li, Hang Yuan, Huikuan Chu, Ling Yang · 2023 · Microorganisms
Effects of obesity on cholesterol metabolism and its implications for healthy ageing
Mark T. Mc Auley · 2020 · Nutrition Research Reviews
Bile acids as regulatory molecules and potential targets in metabolic diseases
Ai-jin Xie, Chu-Tian Mai, Yi Zhun Zhu, Xiancheng Liu, Ying Xie · 2021 · Life Sciences
Association between 12α-hydroxylated bile acids and hepatic steatosis in rats fed a high-fat diet
Shota Hori, Takayuki Abe, Dong Geun Lee, Satoru Fukiya, Atsushi Yokota, Nao Aso, Bungo Shirouchi, Masao Satô, Satoshi Ishizuka · 2020 · The Journal of Nutritional Biochemistry
Pure total flavonoids from citrus attenuate non-alcoholic steatohepatitis via regulating the gut microbiota and bile acid metabolism in mice
Beihui He, Jianping Jiang, Zheng Shi, Liyan Wu, Junbin Yan, Zheng Chen, Minmin Luo, Dawei Cui, Sumei Xu, Maoxiang Yan et al. · 2021 · Biomedicine & Pharmacotherapy
Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets
Cristiana Bianco, Elia Casirati, Francesco Malvestiti, Luca V. C. Valenti · 2021 · JHEP Reports
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, Yoseph Asmelash Gebru, Satya Priya Sharma, Eunju Park, Sung‐Min Won, Jin‐Ju Jeong, Su-Been Lee, Min‐Gi Cha et al. · 2022 · Biomedicines
Circulating Bile Acids as Biomarkers for Disease Diagnosis and Prevention
Qi Li, Yongsheng Chen · 2022 · The Journal of Clinical Endocrinology & Metabolism
The regulation of tissue-specific farnesoid X receptor on genes and diseases involved in bile acid homeostasis
Dong Xiang, Jinyu Yang, Lu Liu, Hengyi Yu, Xuepeng Gong, Dong Liu · 2023 · Biomedicine & Pharmacotherapy
G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment
Ming Jun Yang, Chunye Zhang · 2021 · World Journal of Gastroenterology
ER stress—induced adipocytes secrete-aldo-keto reductase 1B7—containing exosomes that cause nonalcoholic steatohepatitis in mice
Huihui Gu, Kun Yang, Zhentong Shen, Kai Jia, Ping Liu, Miao Pan, Chao Sun · 2020 · Free Radical Biology and Medicine
Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic Steatohepatitis
Jin Chen, Ming‐Hua Zheng, Jun Liu, Yan Luo, Wenjun Yang, Jing Yang, Juan Liu, Zhou Jingxing, Chengfu Xu, Faling Zhao et al. · 2019 · Obesity
Recent advances in understanding and managing non-alcoholic fatty liver disease
Somaya A. M. Albhaisi, Arun Jayant Sanyal · 2018 · F1000Research
Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican‐American Population of South Texas
Suet‐Ying Kwan, Jingjing Jiao, Jonathan Qi, Ying Wang, Peng Wei, Joseph B. McCormick, Susan P. Fisher‐Hoch, Laura Beretta · 2020 · Hepatology Communications
Immune-metabolic interactions in homeostasis and the progression to NASH.
J. Hoogerland, B. Staels, D. Dombrowicz · 2022 · Trends in endocrinology and metabolism
Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH
Hernandez, Gabriella V., Smith, Victoria A., Melnyk, Megan, Burd, Matthew A., Sprayberry, Kimberly A., Edwards, Mark S., Peterson, Daniel G., Bennet, Darin C., Fanter, Rob K., Columbus, Daniel A. et al. · 2020 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Network pharmacology combined with functional metabolomics discover bile acid metabolism as a promising target for mirabilite against colorectal cancer
Hui Juan Sun, Honglian Zhang, Aihua Zhang, Xiaohang Zhou, Xiang‐qian Wang, Ying Han, Guangli Yan, Liang Liu, Xijun Wang · 2018 · RSC Advances
Detangling the interrelations between MAFLD, insulin resistance, and key hormones
Shreya C. Pal, Mohammed Eslam, Nahúm Méndez‐Sánchez · 2022 · HORMONES
Secondary bile acids improve risk prediction for non‐invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease
A‐Na Liu, Cuifang Xu, Ya‐Ru Liu, Dan‐Qin Sun, Ling Jiang, Liang‐Jie Tang, Pei‐Wu Zhu, Sui‐Dan Chen, Wen‐Yue Liu, Xiao‐Dong Wang et al. · 2023 · Alimentary Pharmacology & Therapeutics
Obesity, obesities and gastrointestinal cancers
Yuntao Zou, Capecomorin S. Pitchumoni · 2023 · Disease-a-Month
Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis
David J. Matye, Huaiwen Wang, Wenyi Luo, Rachel R. Sharp, Cheng Chen, Lijie Gu, Kenneth L. Jones, Wen‐Xing Ding, Jacob E. Friedman, Tiangang Li · 2021 · Cellular and Molecular Gastroenterology and Hepatology
The different effects of psyllium husk and orlistat on weight control, the amelioration of hypercholesterolemia and non-alcohol fatty liver disease in obese mice induced by a high-fat diet
Zhitong Deng, Cong Meng, Haodong Huang, Siyu Song, Linchun Fu, Zhuotao Fu · 2022 · Food & Function
Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality
Xia Yi, Mengting Ren, Jinpu Yang, Changzhou Cai, Weixin Cheng, Xinxin Zhou, Dan Lu, Feng Ji · 2022 · Frontiers in Microbiology
The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
Charlotte Lefort, Patrice D. Cani · 2021 · Cells
The prevalence and pregnancy outcomes of intrahepatic cholestasis of pregnancy: A retrospective clinical audit review
Fergus William Gardiner, Ruth McCuaig, Chris Arthur, Thomas Carins, Adam Morton, Josephine Gwyneth Laurie, Teresa M. Neeman, Boon Lim, Michael John Peek · 2018 · Obstetric Medicine
A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non‐Alcoholic Fatty Liver Disease
Petar Petrov, María Victoria García‐Mediavilla, Carla Guzmán, David Porras, Esther Nistal, Susana Martínez‐Flórez, José Vicente Castell, Javier González‐Gallego, Sonia Sánchez‐Campos, Ramiro Jover · 2019 · Molecular Nutrition & Food Research
Ursodeoxycholic Acid Alters Bile Acid and Fatty Acid Profiles in a Mouse Model of Diet-Induced Obesity
Yunjing Zhang, Xiaojiao Zheng, Fengjie Huang, Aihua Zhao, Kun Ge, Qing Zhao, Wei Ping Jia · 2019 · Frontiers in Pharmacology
The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
Yiming Ni, Mengna Lu, Yuan Xu, Qixue Wang, Xinyi Gu, Ying Li, Tongxi Zhuang, Chenyi Xia, Ting Zhang, Xiaojun Gou et al. · 2022 · Frontiers in Microbiology
Bile Acid Metabolism in Health and Disease
Tiangang Li, John Y.L. Chiang · 2020 · Wiley eBooks
Plasma Metabolomics and Machine Learning-Driven Novel Diagnostic Signature for Non-Alcoholic Steatohepatitis
Moongi Ji, Yunju Jo, Seung Joon Choi, Seong Min Kim, Kyoung Kon Kim, Byung‐Chul Oh, Dongryeol Ryu, Man‐Jeong Paik, Dae Ho Lee · 2022 · Biomedicines
Circulating lipidomic alterations in obese and non‐obese subjects with non‐alcoholic fatty liver disease
Youngae Jung, Min Kyung Lee, Puneet Puri, Bo Kyung Koo, Sae Kyung Joo, Seo Young Jang, Dong Hyeon Lee, Yong Jin Jung, Byeong Gwan Kim, Kook Lae Lee et al. · 2020 · Alimentary Pharmacology & Therapeutics
The altered lipidome of hepatocellular carcinoma
Shawn Lu Wen Tan, Erez Israeli, Russell Erick Ericksen, Pierce K. H. Chow, Weiping Han · 2022 · Seminars in Cancer Biology
Deoxycholic Acid Promotes Pyroptosis in Free Fatty Acid-Induced Steatotic Hepatocytes by Inhibiting PINK1-Mediated Mitophagy
Xuebin Gao, Yongdui Ruan, Xuan Zhu, Xiaozhuan Lin, Xin Yan, Xiang Li, Meiqing Mai, Honghui Guo · 2021 · Inflammation
Bile acid and nonalcoholic steatohepatitis: Molecular insights and therapeutic targets
Zilu Cheng, Yixiong Chen, Bernd Schnabl, Huikuan Chu, Ling Yang · 2023 · Journal of Advanced Research
A Current Understanding of FXR in NAFLD: The multifaceted regulatory role of FXR and novel lead discovery for drug development
Yuhong Tang, Yujuan Fan, Yiming Wang, Dong Wang, Qingyu Huang, Tongqing Chen, Xinyue Cao, Cailing Wen, Xiaoyan Shen, Jian Li et al. · 2024 · Biomedicine & Pharmacotherapy
Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease
Jakub Rochoń, Piotr Kalinowski, Ksenia Szymanek-Majchrzak, Michał Grąt · 2024 · World Journal of Gastroenterology
Modulation of the fecal microbiome and metabolome by resistant dextrin ameliorates hepatic steatosis and mitochondrial abnormalities in mice
Zheng Zhang, Xiao Chen, Bo Cui · 2021 · Food & Function
Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review
Jacqueline Hoozemans, Maurits de Brauw, Max Nieuwdorp, Victor E. A. Gerdes · 2021 · Metabolites
Bile acids and sphingolipids in non-alcoholic fatty liver disease
Kaitlyn G. Jackson, Grayson W. Way, Huiping Zhou · 2022 · Chinese Medical Journal
The contribution of the gut-liver axis to the immune signaling pathway of NAFLD
Jiayi Liu, Anding Wu, Jingjing Cai, Zhi‐Gang She, Hongliang Li · 2022 · Frontiers in Immunology
Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
Chao Yang, Min Wan, Dengfeng Xu, Da Pan, Hui Xia, Ligang Yang, Guiju Sun · 2021 · International Journal of Molecular Sciences
FXR and NASH: an avenue for tissue-specific regulation
Zakiyah R Henry, Vik Meadows, Grace Liejun Guo · 2023 · Hepatology Communications
Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review
Eider Talavera-Urquijo, Marc Beisani, José María Balibrea, John C. Alverdy · 2020 · Surgery for Obesity and Related Diseases
Obeticholic Acid Inhibits Anxiety via Alleviating Gut Microbiota-Mediated Microglia Accumulation in the Brain of High-Fat High-Sugar Diet Mice
Li Ming Wu, Yuqiu Han, Zhipeng Zheng, Shuai Zhu, Jun Chen, Yuanyuan Yao, Siqing Yue, Andreas Teufel, Honglei Weng, Lanjuan Li et al. · 2021 · Nutrients
Salvia-Nelumbinis naturalis extract protects mice against MCD diet-induced steatohepatitis via activation of colonic FXR-FGF15 pathway
Chunlin Li, Wenjun Zhou, Meng Li, Xiangbing Shu, Li Rita Zhang, Guang Ji · 2021 · Biomedicine & Pharmacotherapy
Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational Study
Yuki Kasai, Takaomi Kessoku, Kosuke Tanaka, Atsushi Yamamoto, Kota Takahashi, Takashi Kobayashi, Michihiro Iwaki, Anna Ozaki, Asako Nogami, Yasushi Honda et al. · 2022 · Clinical and Translational Gastroenterology
Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
Qi Zhang, Wenmin Xing, Qiao Wang, Zhan Tang, Yazhen Wang, Wenyan Gao · 2022 · Frontiers in Nutrition
Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review)
Qun Liu, Shousheng Liu, Lizhen Chen, Zhenzhen Zhao, Shui-Xian Du, Quanjiang Dong, Yongning Xin, Shiying Xuan · 2019 · Experimental and Therapeutic Medicine
Role of Bile Acids and Bile Salts in Acute Pancreatitis
Quang Trung Tran, Van Huy Tran, Matthias Sendler, Julia Doller, Mats Lukas Wiese, Robert Bolsmann, Anika Wilden, Juliane Glaubitz, Jana Marielle Modenbach, Franziska Gisela Thiel et al. · 2020 · Pancreas
Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice
Rongrong Zhou, Cristina Llorente, Jinling Cao, Livia Soares Zaramela, Su-Ling Zeng, Bei Gao, Shang‐Zhen Li, Ryan D. Welch, Feng‐Qing Huang, Lian‐Wen Qi et al. · 2021 · Cellular and Molecular Gastroenterology and Hepatology
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease
Michele Biagioli, Stefano Fiorucci · 2021 · Liver Research
Metabolomics at the cutting edge of risk prediction of MASLD
En Ying Tan, Mark Dhinesh Muthiah, Arun Jayant Sanyal · 2024 · Cell Reports Medicine
Plasma metabolic alterations in patients with severe obesity and non‐alcoholic steatohepatitis
Noemí Cabré, Fedra Luciano‐Mateo, Gerard Baiges‐Gayà, Salvador Fernández‐Arroyo, Elisabet Rodríguez‐Tomàs, Anna Hernández‐Aguilera, Marta París, Fàtima Sabench, Daniel Del Castillo, José López‐Miranda et al. · 2019 · Alimentary Pharmacology & Therapeutics
Circulating bile acid concentrations and non‐alcoholic fatty liver disease in Guatemala
Alvaro Rivera‐Andrade, Jessica L. Petrick, Christian S. Álvarez, Barry I. Graubard, Andrea A. Florio, Maria Fernanda Kroker-Lobos, Dominick Parisi, Neal D. Freedman, Mariana Lazo, Eliseo Güallar et al. · 2022 · Alimentary Pharmacology & Therapeutics
Targeting bile acid signaling for the treatment of liver diseases: From bench to bed
Shuni Duan, Xiaojiaoyang Li, Guifang Fan, Runping Liu · 2022 · Biomedicine & Pharmacotherapy
Sterol 12α-Hydroxylase Aggravates Dyslipidemia by Activating the Ceramide/mTORC1/SREBP-1C Pathway via FGF21 and FGF15
Preeti Pathak, John Y.L. Chiang · 2019 · Gene Expression
The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation
Nadia Panera, Marica Meroni, Miriam Longo, Annalisa Crudele, Luca V. C. Valenti, Emanuele Bellacchio, Luca Miele, Valentina Doria, Erika Paolini, Marco Maggioni et al. · 2021 · EBioMedicine
The Presence and Severity of Nonalcoholic Steatohepatitis Is Associated with Specific Changes in Circulating Bile Acids
Aline Gottlieb, Lars P. Bechmann, Ali E. Canbay · 2018 · Annals of Hepatology
Potential therapeutic strategies for MASH: from preclinical to clinical development
Zhifu Xie, Yufeng Li, Long Cheng, Yidan Huang, Wanglin Rao, Honglu Shi, Jingya Li · 2024 · Life Metabolism
Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver disease
Buchynskyi, Mykhailo, Kamyshna, Iryna, Halabitska, Iryna, Petakh, Pavlo, Kunduzova, Oksana, Oksenych, Valentyn, Kamyshnyi, Oleksandr · 2025 · Frontiers in Microbiology
“Trust your gut”: exploring the connection between gut microbiome dysbiosis and the advancement of Metabolic Associated Steatosis Liver Disease (MASLD)/Metabolic Associated Steatohepatitis (MASH): a systematic review of animal and human studies
Wesam Bahitham, Yusra Banoun, Mutep Aljahdali, Ghufran Almuaiqly, Shahad M. Bahshwan, Linah Aljahdali, Faisal M. Sanai, Alexandre Soares Rosado, Consolato Maria Sergi · 2025 · Frontiers in Nutrition
Serum Bile Acid Profiles Improve Clinical Prediction of Nonalcoholic Fatty Liver in T2DM patients
Tao Wu, Ming Shu Yang, Hanchen Xu, Lei Wang, Huafeng Wei, Guang Ji · 2021 · Journal of Proteome Research
Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus
Youngae Jung, Bo Kyung Koo, Seo Young Jang, Dain Raina Kim, Heeyeon Lee, Dong Hyeon Lee, Sae Kyung Joo, Yong Jin Jung, Jeong Hwan Park, Taekyeong Yoo et al. · 2021 · Liver International
Inulin activates FXR-FGF15 signaling and further increases bile acids excretion in non-alcoholic fatty liver disease mice
Rui Wang, Yi Ren, Ting Bao, Ting Wang, Yiwei Li, Yuanyuan Liu, Xiaoxia Zhang, Shaoqi Yang, Hao Wang · 2022 · Biochemical and Biophysical Research Communications
Effects of supplemented isoenergetic diets varying in cereal fiber and protein content on the bile acid metabolic signature and relation to insulin resistance
Weickert, Martin O., Hattersley, John G., Kyrou, Ioannis, Arafat, Ayman M., Rudovich, Natalia, Roden, Michael, Nowotny, Peter, von Loeffelholz, Christian, Matysik, Silke, Schmitz, Gerd et al. · 2018 · Nutrition & Diabetes
Bioaccumulation and metabolic impact of environmental PFAS residue on wild-caught urban wetland tiger snakes (Notechis scutatus)
Damian Christopher Lettoof, Vy Nguyen, William R. Richmond, Helen E. Nice, Marthe Monique Gagnon, David J. Beale · 2023 · The Science of The Total Environment
Gender-Specific Bile Acid Profiles in Non-Alcoholic Fatty Liver Disease
Julia Fitzinger, Giovanny Rodriguez Blanco, Markus Herrmann, Andrea Borenich, Rudolf E Stauber, Elmar Stephan Aigner, Harald Mangge · 2024 · Nutrients
Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline‐Deficient (MCD) Diet‐induced Nonalcoholic Steatohepatitis (NASH) Mice
Fei Xiong, Zhongdaixi Zheng, Lingyu Xiao, Chuhong Su, Junbin Chen, Xiangfu Gu, Jiaqi Tang, Yue Zhao, Huiyu Luo, Longying Zha · 2021 · Molecular Nutrition & Food Research
A prospective investigation of serum bile acids with risk of liver cancer, fatal liver disease, and biliary tract cancer
Zeinab Farhat, Neal D. Freedman, Joshua Neil Sampson, Roni T. Falk, Jill E. Koshiol, Stephanie J. Weinstein, Demetrius Albanes, Rashmi R. Sinha, Erikka Loftfield · 2022 · Hepatology Communications
The Interplay of TGF-β1 and Cholesterol Orchestrating Hepatocyte Cell Fate, EMT, and Signals for HSC Activation
Sai Wang, Frederik Link, Mei Han, Roohi Chaudhary, Anastasia Asimakopoulos, Roman Liebe, Ye Yao, Seddik Hammad, Anne Dropmann, Marinela Krizanac et al. · 2023 · Cellular and Molecular Gastroenterology and Hepatology
High fat diet incorporated with meat proteins changes biomarkers of lipid metabolism, antioxidant activities, and the serum metabolomic profile in Glrx1 −/− mice
Muhammad Ijaz Ahmad, Muhammad Umair Ijaz, Muzahir Hussain, Iftikhar Ali Khan, Noreen Mehmood, Sultan Mehmood Siddiqi, Congcong Liu, Di Zhao, Xinglian Xu, Guanghong Zhou et al. · 2019 · Food & Function
Glycine‐β‐muricholic acid antagonizes the intestinal farnesoid X receptor–ceramide axis and ameliorates NASH in mice
Jie Jiang, Yuandi Ma, Yameng Liu, Dasheng Lu, Xiaoxia Gao, Kristopher W. Krausz, Dhimant H. Desai, Shantu Amin, Andrew D. Patterson, Frank J. Gonzalez et al. · 2022 · Hepatology Communications
Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications
Tiziana Fernández, Felipe Andrés Contreras Briceño, Maximiliano Espinosa‐Ramírez, Patricio García-Valdés, Antonio López‐Fuenzalida, Arnoldo J. Riquelme, Juan Pablo Arab, Daniel Cabrera, Marco A. Arrese, Francisco Barrera M. · 2020 · Expert Review of Gastroenterology & Hepatology
A new mechanism of thyroid hormone receptor β agonists ameliorating nonalcoholic steatohepatitis by inhibiting intestinal lipid absorption via remodeling bile acid profiles
Kai Sun, Nan-Lin Zhu, Suling Huang, Hui Yan Qu, Yipei Gu, Qin Li, Jia Liu, Ying Leng · 2024 · Acta Pharmacologica Sinica
Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver disease
Michael A Trauner, Saul J. Karpen, Paul A. Dawson · 2025 · Hepatology
Absence of Bsep/Abcb11 attenuates MCD diet‐induced hepatic steatosis but aggravates inflammation in mice
Claudia Daniela Fuchs, Sebastian Krivanec, Daniel Steinacher, Veronika Mlitz, Annika M. Wahlstrom, Marcus Ståhlman, Thierry Claudel, Hubert Scharnagl, Tatjana Stojaković, Hanns–Ulrich Marschall et al. · 2020 · Liver International
Bioactive metabolites: A clue to the link between MASLD and CKD?
Wen‐Ying Chen, Jia-Hui Zhang, Lili Chen, Christopher D. Byrne, Giovanni Targher, Liangping Luo, Yan Ni, Ming‐Hua Zheng, Dan‐Qin Sun · 2024 · Clinical and Molecular Hepatology
Liver inflammation at the time of spinal cord injury enhances intraspinal pathology, liver injury, metabolic syndrome and locomotor deficits
Matthew T. Goodus, Kaitlin E. Carson, Andrew D. Sauerbeck, Priyankar Dey, Anthony N. Alfredo, Phillip G. Popovich, Richard S. Bruno, Dana M. McTigue · 2021 · Experimental Neurology
Elevated serum levels of diamine oxidase, D-lactate and lipopolysaccharides are associated with metabolic-associated fatty liver disease
Ruike Zhang, Yanan Chen, Jixia Zhang, Jing Liu · 2022 · European Journal of Gastroenterology & Hepatology
The Dynamic Role of Endoplasmic Reticulum Stress in Chronic Liver Disease
Kaitlyn G. Jackson, Grayson W. Way, Jing Zeng, Marissa K. Lipp, Huiping Zhou · 2023 · American Journal Of Pathology
Bile acids in nonalcoholic steatohepatitis: Pathophysiological driving force or innocent bystanders?
Daniel Jahn, Andreas Geier · 2017 · Hepatology
Nutritional Modulation of Innate Immunity: The Fat–Bile–Gut Connection
Raphaël Chèvre, Carlos Silvestre-Roig, Oliver Soehnlein · 2018 · Trends in Endocrinology and Metabolism
The structure and characterization of human cytochrome P450 8B1 supports future drug design for nonalcoholic fatty liver disease and diabetes
Jinghan Liu, Heather A. Carlson, Emily E. Scott · 2022 · Journal of Biological Chemistry
Bile salt signaling and bile salt-based therapies in cardiometabolic disease
Claire Groenen, Thuc-Anh Nguyen, Coen C. Paulusma, Stan F.J. van de Graaf · 2024 · Clinical Science
The biochemical diagnosis of intrahepatic cholestasis of pregnancy
Adam Morton, Josephine Gwyneth Laurie · 2018 · Obstetric Medicine
Atorvastatin Modulates Bile Acid Homeostasis in Mice with Diet-Induced Nonalcoholic Steatohepatitis
Hana Laštůvková, Fatemeh Alaei Faradonbeh, Jolana Schreiberová, Milos Hroch, Jaroslav Mokrý, Hana Faistova, Zuzana Nová, Radomı́r Hyšpler, Ivone Cristina Igreja, Petr Nachtigal et al. · 2021 · International Journal of Molecular Sciences
Heat-Inactivated Akkermansia muciniphila Improves Gut Permeability but Does Not Prevent Development of Non-Alcoholic Steatohepatitis in Diet-Induced Obese Ldlr−/−.Leiden Mice
Martine C. Morrison, Eveline Gart, Wim van Duyvenvoorde, Jessica M. Snabel, Mette Juul Nielsen, Diana Julie Leeming, Aswin L. Menke, Robert Kleemann · 2022 · International Journal of Molecular Sciences